Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1530/eje.0.1510539
European Journal of Endocrinology, Vol 151, Issue 5, 539-548
Copyright © 2004 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schlumberger, M
Right arrow Articles by Berg, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schlumberger, M
Right arrow Articles by Berg, G
Case Reports

Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice

M Schlumberger, F Pacini, WM Wiersinga, A Toft, JW Smit, F Sanchez Franco, P Lind, E Limbert, B Jarzab, F Jamar, L Duntas, O Cohen, and G Berg

Service de Medicine Nucleaire, Institut Gustave Roussy, 94805 Villejuif, France. schlumbg@igr.fr

As differentiated (follicular and papillary) thyroid cancer (DTC) may recur years after initial treatment, follow-up of patients with DTC is long term. However, this population has changed, with more individuals being discovered at an earlier stage of disease, so that previous follow-up protocols based mostly on data from high-risk patients no longer apply. We have proposed, in a previous issue of this Journal, an improved protocol for the follow-up of low-risk patients with DTC based on the findings of recent studies. We report here the case of a paradigmatic patient with papillary thyroid carcinoma, with the goal of illustrating the benefits of applying this algorithm in routine clinical practice. We also offer expanded and additional comments on various issues in the management of DTC.


This article has been cited by other articles:


Home page
 JNMHome page
R. M. Tuttle, M. Brokhin, G. Omry, A. J. Martorella, S. M. Larson, R. K. Grewal, M. Fleisher, and R. J. Robbins
Recombinant Human TSH-Assisted Radioactive Iodine Remnant Ablation Achieves Short-Term Clinical Recurrence Rates Similar to Those of Traditional Thyroid Hormone Withdrawal
J. Nucl. Med., May 1, 2008; 49(5): 764 - 770.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. G. Castagna, L. Brilli, T. Pilli, A. Montanaro, C. Cipri, C. Fioravanti, F. Sestini, M. Capezzone, and F. Pacini
Limited Value of Repeat Recombinant Human Thyrotropin (rhTSH)-Stimulated Thyroglobulin Testing in Differentiated Thyroid Carcinoma Patients with Previous Negative rhTSH-Stimulated Thyroglobulin and Undetectable Basal Serum Thyroglobulin Levels
J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 76 - 81.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
N. Cunha, F. Rodrigues, F. Curado, O. Ilheu, C. Cruz, P. Naidenov, M. J. Rascao, J. Ganho, I. Gomes, H. Pereira, et al.
Thyroglobulin detection in fine-needle aspirates of cervical lymph nodes: a technique for the diagnosis of metastatic differentiated thyroid cancer
Eur. J. Endocrinol., July 1, 2007; 157(1): 101 - 107.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
I Borget, C Corone, M Nocaudie, M Allyn, S Iacobelli, M Schlumberger, and G De Pouvourville
Sick leave for follow-up control in thyroid cancer patients: comparison between stimulation with Thyrogen and thyroid hormone withdrawal
Eur. J. Endocrinol., May 1, 2007; 156(5): 531 - 538.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. Triponez, L. Poder, R. Zarnegar, R. Goldstein, K. Roayaie, V. Feldstein, J. Lee, E. Kebebew, Q.-Y. Duh, and O. H. Clark
Hook Needle-Guided Excision of Recurrent Differentiated Thyroid Cancer in Previously Operated Neck Compartments: A Safe Technique for Small, Nonpalpable Recurrent Disease
J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4943 - 4947.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
F. Pacini, M. Schlumberger, H. Dralle, R. Elisei, J. W A Smit, W. Wiersinga, and the European Thyroid Cancer Taskforce
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium.
Eur. J. Endocrinol., June 1, 2006; 154(6): 787 - 803.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. C.M. Persoon, J. M.W. Van Den Ouweland, J. Wilde, I. P. Kema, B. H.R. Wolffenbuttel, and T. P. Links
Clinical utility of an automated immunochemiluminometric thyroglobulin assay in differentiated thyroid carcinoma.
Clin. Chem., April 1, 2006; 52(4): 686 - 691.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
F. Pacini, M. Schlumberger, C. Harmer, G. G Berg, O. Cohen, L. Duntas, F. Jamar, B. Jarzab, E. Limbert, P. Lind, et al.
Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report
Eur. J. Endocrinol., November 1, 2005; 153(5): 651 - 659.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. A. Spencer, L. M. Bergoglio, M. Kazarosyan, S. Fatemi, and J. S. LoPresti
Clinical Impact of Thyroglobulin (Tg) and Tg Autoantibody Method Differences on the Management of Patients with Differentiated Thyroid Carcinomas
J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5566 - 5575.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 European Society of Endocrinology.